Is Weakness In Charles River Laboratories International, Inc. (NYSE:CRL) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Is Weakness In Charles River Laboratories International, Inc. (NYSE:CRL) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Charles River Laboratories International (NYSE:CRL) has had a rough three months with its share price down 20%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. Specifically, we decided to study Charles River Laboratories International's ROE in this article.
納斯達克:CRL的股價過去3個月下跌了20%。但是，仔細看看其穩健的財務狀況可能會使您重新考慮。鑑於基本面通常決定着長期市場結果，有必要關注該公司。本文將重點研究Charles River Laboratories International的ROE。
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
股東必須考慮股本回報率或ROE，因爲它告訴他們公司如何有效地重新投資他們的資本。 簡而言之，ROE顯示每美元股東投資所產生的利潤。
How To Calculate Return On Equity?
如何計算股東權益報酬率？
The formula for return on equity is:
權益回報率的計算公式是：
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
淨資產收益率 = 淨利潤（從持續經營中獲得）÷ 股東權益
So, based on the above formula, the ROE for Charles River Laboratories International is:
因此，根據上述公式，Charles River Laboratories International的ROE爲：
12% = US$451m ÷ US$3.7b (Based on the trailing twelve months to March 2024).
12%= 45.1億美元 ÷ 37億美元（基於截至2024年3月的過去12個月）
The 'return' is the amount earned after tax over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.12.
“回報”指過去12個月稅後收益。這意味着該公司爲其股東的每一美元投資創造了0.12美元的淨利潤。
What Has ROE Got To Do With Earnings Growth?
ROE與盈利增長有什麼關係？
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
我們已經確定ROE是衡量公司未來盈利能力的有效指標。基於公司選擇再投資或“留存”利潤的比例，我們可以評估公司未來生成利潤的能力。其他條件相同的情況下，具有更高淨資產收益率和更高利潤留存率的公司通常比沒有這些特點的公司增長率更高。
Charles River Laboratories International's Earnings Growth And 12% ROE
Charles River Laboratories International股票的收益增長和12%的roe
At first glance, Charles River Laboratories International seems to have a decent ROE. Even when compared to the industry average of 12% the company's ROE looks quite decent. Consequently, this likely laid the ground for the decent growth of 16% seen over the past five years by Charles River Laboratories International.
乍一看，Charles River Laboratories International的ROE似乎相當不錯，即使與行業平均水平的12%相比，該公司的ROE看起來也相當不錯。因此，這可能締造了Charles River Laboratories International過去五年16%的不俗增長。
Next, on comparing Charles River Laboratories International's net income growth with the industry, we found that the company's reported growth is similar to the industry average growth rate of 17% over the last few years.
接下來，與行業相比較Charles River Laboratories International的淨利潤增長，我們發現該公司報告的增長類似於過去幾年行業平均增長率的17%。
Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. What is CRL worth today? The intrinsic value infographic in our free research report helps visualize whether CRL is currently mispriced by the market.
收益增長是估值股票時需要考慮的重要指標。投資者應嘗試確定預期收益增長或下降，無論哪種情況，是否已計價。然後，這有助於他們判斷該股票是否面臨光明或黯淡的未來。CRL今天值多少錢？我們免費的研究報告中的內在價值信息圖表有助於可視化CRL是否目前被市場錯誤定價。
Is Charles River Laboratories International Using Its Retained Earnings Effectively?
Charles River Laboratories International有效利用保留利潤嗎？
Given that Charles River Laboratories International doesn't pay any regular dividends to its shareholders, we infer that the company has been reinvesting all of its profits to grow its business.
鑑於Charles River Laboratories International不向其股東支付任何定期股息，我們推斷該公司一直在重新投資其所有利潤來擴大業務。
Summary
總的來說，我們對偉明環保的表現非常滿意。具體而言，我們喜歡公司以高回報率再投資了其利潤的很大一部分。當然，這導致公司的收益大幅增長。但是，最新的行業分析師預測表明，該公司的收益預計將加速增長。
In total, we are pretty happy with Charles River Laboratories International's performance. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. That being so, a study of the latest analyst forecasts show that the company is expected to see a slowdown in its future earnings growth. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.
總體來說，我們對Charles River Laboratories International的表現非常滿意，特別是我們喜歡該公司大量投入資金到其業務中，並以高回報率增長。不出所料，這導致了可觀的盈利增長。雖然如此，對最新分析師預測的研究顯示該公司未來預計會看到盈利增長放緩。要了解有關該公司的最新分析師預測的更多信息，請查看此可視化分析師預測公司。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋？關於內容有所顧慮？直接和我們聯繫。或者，發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論，只使用公正的方法論，我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議，也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意，我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有反饋？關於內容有所顧慮？直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。
譯文內容由第三人軟體翻譯。